Utilization of hepatocellular carcinoma surveillance among American patients: A systematic review

218Citations
Citations of this article
96Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Although surveillance for hepatocellular carcinoma (HCC) is recommended in high-risk patients, several studies have suggested it is being underutilized in clinical practice. The aim of our study was to quantify utilization rates for HCC surveillance among patients with cirrhosis and summarize patterns of association between utilization rates and patient socio-demographic characteristics. DATA SOURCES: We performed a systematic literature review using the Medline database from January 1990 through March 2011 and a manual search of national meeting abstracts from 2008-2010. METHODS: Two investigators independently extracted data on patient populations, study methods, and results using standardized forms. A pooled surveillance rate with 95% confidence intervals was calculated. Pre-specified subgroup analysis was performed to find correlates of surveillance utilization. RESULTS: We identified nine studies that met inclusion criteria. The pooled surveillance rate was 18.4% (95%CI 17.8%-19.0%). Surveillance rates were significantly higher among patients followed in subspecialty gastroenterology clinics compared to those followed in primary care clinics (51.7% vs. 16.9%, p∈

Cite

CITATION STYLE

APA

Singal, A. G., Yopp, A., S. Skinner, C., Packer, M., Lee, W. M., & Tiro, J. A. (2012, July). Utilization of hepatocellular carcinoma surveillance among American patients: A systematic review. Journal of General Internal Medicine. https://doi.org/10.1007/s11606-011-1952-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free